BridgeMD
Tests treatment safety and results for Carpal Tunnel Syndrome
Official title Efficacy of Combining Ultrasound-Guided Needle Release of Transverse Carpal Ligament and Median Nerve Dextrose Water Hydrodissection for Carpal Tunnel Syndrome
ClinicalTrials.gov ID: NCT07324005
What this study is testing
- What it's testing
- Carpal tunnel syndrome (CTS) is a common musculoskeletal disorder, which is caused by compression of the median nerve as it travels through the wrist. There are several treatments for CTS, including conservative and surgical options.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 20 to 80
You may be able to join if
- age between 20 to 80 years old
- diagnosed with CTS on the basis of clinical condition and an electrophysiological analysis
- the NRS of pain or paresthesia≧3
- with symptoms lasting for a minimum of 3 months.
You likely can't join if
- history of polyneuropathy, thoracic outlet syndrome, brachial plexopathy, or inflammatory arthropathy
- onset of CTS during pregnancy, hypothyroidism, or systemic infection
- previous corticosteroid injection or wrist surgery for CTS
- hypersensitivity to dextrose injection
- the anatomic structure of the wrist is not suitable for needle release of TCL.
The study team makes the final eligibility decision.
Where it's taking place
- Taipei, Taiwan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 20 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Taipei, Taiwan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.